Evidence search

Evidence search for the S3 guideline on peri- and postmenopause - diagnostics and interventions

Status
Status: Commission completed
Project no.
V24-05
Last updated

Report documents

  1. Evidence report

    V24-05A: Cognitive behavioural therapy: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions

    published on
    Document type
    PDF document, 707 kB, DE, not accessible
    DOI-Link
    https://doi.org/10.60584/V24-05A
  2. Evidence report

    V24-05B: Isoflavone: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions

    published on
    Document type
    PDF document, 1 MB, DE, not accessible
    DOI-Link
    https://doi.org/ 10.60584/V24-05B
  3. Evidence report

    V24-05C: Cimicifuga: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions

    published on
    Document type
    PDF document, 576 kB, DE, not accessible
    DOI-Link
    https://doi.org/10.60584/V24-05C
  4. Evidence report

    V24-05D: SSRI/SSNRI: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions

    published on
    Document type
    PDF document, 1 MB, DE, not accessible
    DOI-Link
    https://doi.org/10.60584/V24-05D
  5. Evidence report

    V24-05E: Clonidine: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions

    published on
    Document type
    PDF document, 413 kB, DE, not accessible
    DOI-Link
    https://doi.org/10.60584/V24-05E
  6. Evidence report

    V24-05F: Gabapentin: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions

    published on
    Document type
    PDF document, 780 kB, DE, not accessible
    DOI-Link
    https://doi.org/10.60584/V24-05F

Project details

Project no.
V24-05
Commission
Commission awarded on 16.05.2024 by the Federal Ministry of Health (BMG).
Report type
Evidence search
Status
Commission completed
Department/Division
Health Care and Guidelines
Topic
DMP and clinical pratice guidelines
Note

The search for evidence on the S3 guideline on peri- and postmenopause - diagnostics and interventions covers 6 evidence reports.

DOI

https://doi.org/10.60584/V24-05A: Cognitive behavioural therapy: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05A)

https://doi.org/10.60584/V24-05B: Isoflavone: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05B)

https://doi.org/10.60584/V24-05C: Cimicifuga: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05C)

https://doi.org/10.60584/V24-05D: SSRI/SSNRI: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05D)

https://doi.org/10.60584/V24-05E: Clonidine: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (24-05E)

https://doi.org/10.60584/V24-05F: Gabapentin: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions (V24-05F)

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form